RACHAEL GREGORY: Open Payments
NPI 1992093272 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,629 in 17 payments from 8 companies in 2025. Trend: 2023 $5,581 · 2024 $7,403 · 2025 $1,629
Consulting: $1,120Food & beverage: $509
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 8 | $1,408 |
| ABBVIE INC. | 2 | $53 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| Neurelis, Inc. | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Alexion Pharmaceuticals, Inc. | 1 | $25 |
| PFIZER INC. | 1 | $22 |
| Janssen Biotech, Inc. | 1 | $17 |
Products named: Briviact, Nayzilam, BOTOX, KESIMPTA, VALTOCO, REXULTI, ULTOMIRIS, Fintepla.
Industry payments across NV — which companies pay providers there.
